Time to diagnosis in systemic sclerosis: Is sex a factor?

Arthritis Care and Research

Volumn 61, Issue 2, 2009, Pages 274-278

  Hudson, Marie ^a   Thombs, Brett ^a   Baron, Murray ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSIS; DIFFUSE SCLERODERMA; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RAYNAUD PHENOMENON; SELF REPORT; SEX DIFFERENCE; SYSTEMIC SCLEROSIS; TIME;

CANADA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; RAYNAUD DISEASE; REGISTRIES; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; SEX FACTORS; TIME;

EID: 62549164691     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24284     Document Type: Article

References (12)

1. Block J, Sequeira W. Raynaud's phenomenon. Lancet 2001; 357:2042-8.
2. Barsky A, Peekna H, Borus J. Somatic symptom reporting in women and men. J Gen Intern Med 2001;16:266-75.
3. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
4. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
5. Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 2008;37:223-35.
6. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006;354:2655-66.
7. Clements PJ, Furst DE, Wong WK, Mayes M, White B, Wigley F, et al. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum 1999;42:1194-203.
8. Johnson S, Carette S, Dunne J. Scleroderma: health services utilization from patients' perspective. J Rheumatol 2006;33:1123-7.
9. Meyer OC, Fertig N, Lucas M, Somogyi N, Medsger TA. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol 2007;34:104-9.
10. Seibold J. Scleroderma. In: Harris E, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, et al, editors. Kelley's textbook of rheumatology. 7th ed. Philadelphia: Elsevier;2005.
11. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-44.
12. Olson RA. A piece of my mind: the need to know. JAMA 2007;297:787-8.